go-v.orgdoi

Sphingosomes: A Novel Vesicular Drug Delivery System

Maimuna Fatima, C. V. Sai Sravani, K. Latha, M. Sujatha · European journal of parenteral & pharmaceutical sciences · 2026

  • DOI 10.37521/ejpps31207
  • Publisher OpenAlex
  • Type article
  • Issued 2026

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

European journal of parenteral & pharmaceutical sciences · OpenAlex · article · 2026

Abstract

This novel drug delivery system strives to sustain drug effect at a pre-determined rate or keep up a relatively constant and effective drug amount within the body, along with concomitant reduction in undesirable side effects. Vesicular systems consist of highly ordered assemblies of one or several concentric lipid-bilayers. By enclosing an active medication inside the vesicular structures such as niosomes, liposomes, ethosomes, and pharmacosomes, a transferosomes enhanced therapeutic index can be acquired for both new and existing drug molecules. Sphingosomes are one such system in which aqueous volume is thoroughly bound to a sphingolipid-bilayer membrane.

Sphingosomes resolve the vital downsides of vesicle systems (niosomes, liposomes) such as low stability, poor tumour stocking potency in cancer treatment and less in-vivo circulation time. The present overview indicates that this vesicular system represents a propitious system of drug delivery to supply curative compounds for a vast span of feasible applications. Keywords: Sphingosomes, Cholesterol, Vesicular systems, Sphingolipids, Lipid-bilayers, Niosomes, Liposomes.

Open the resolved locator · 10.37521/ejpps31207

Metadata licence: OpenAlex metadata (CC0)